My PCR
Create Account
Logo PCR

20 May 2026

Stents, scaffolds and DCBOther peripheral interventions

MagicTouch sirolimus-coated balloon for coronary artery disease and peripheral artery disease treatment: where evidence meets experience

Sponsored by Concept Medical

Anchorperson: M. Leon
Spokespersons: A. Abizaid, D. Scheinert
SHOW MORE

Summary

This session examines the clinical evidence and experiential insights regarding the MagicTouch sirolimus-coated balloon (SCB) for treating coronary and peripheral artery disease. It reviews long-term comparative data versus paclitaxel-coated balloons, application techniques, integration into current practices, and findings from major trials such as SIRONA and SIMPLE-DM, providing an evidence-based approach to SCB utilisation.

Learning Objectives

  • To know the available clinical evidence of sirolimus-coated balloon (SCB) in peripheral artery disease treatment from a long-term direct comparison with paclitaxel-coated balloon and the largest randomised controlled trial against uncoated balloon in all comers population
  • To learn from the experts through case-based insights on how to integrate the techniques to use SCB in various indications to formulate evidence-based strategies
  • To discuss on how sirolimus-coated balloon has the potential to synchronise with your current treatment practice in coronary artery disease and peripheral artery disease with an experience and evidence-based approach
Related Content
The next frontier of DCB is to simplify complexity ISR: sirolimus balloon vs DES or standard PCI A novel bailout technique for the percutaneous extraction of an entrapped coronary guidewire beneath a crushed stent
Recommended for you
AICT-AsiaPCR 2026: what’s new this year? 1-year SELUTION DeNovo results: DEB strategy vs. systematic DES in de novo coronary disease IRONMAN II: 2-year outcomes of sirolimus-eluting bioresorbable scaffolds vs. DES